News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Beximco Pharmaceuticals Announces Financial Results for Nine Months Ended September, 2010


10/29/2010 11:22:25 AM

29th October, 2010 -- Beximco Pharmaceuticals Limited (“BPL” or “Company”; AIM Symbol: BXP) today announces its unaudited financial results for the nine month period ended 30 September 2010. The information set out below has been released to the Dhaka and Chittagong Stock Exchanges in compliance with the requirements from the Bangladesh SEC.

The accounts can be viewed at the Company’s website: www.beximcopharma.com

For further enquiries please contact:

Beximco Pharma Nazmul Hassan MP, Managing Director Tel: +880 2 861 9151, ext.2080

Md. Asad Ullah, FCS, Executive Director & Company Secretary Tel: +880 2 8618220-1, Ext 1140

Libertas Capital Corporate Finance Jakob Kinde / Anthony Rowland Tel: +44 (0)20 7569 9650

Financial Dynamics Jonathan Birt / Susan Quigley Tel: +44 (0)20 7269 7169

About Beximco Pharmaceuticals Limited

Founded in 1976 and based in Dhaka, Bangladesh, BPL manufactures and sells generic pharmaceutical formulation products, active pharmaceutical ingredients and intravenous fluids. The Company also manufactures and markets its own branded generics for almost all diseases. The Company also undertakes contract manufacturing for multinational pharmaceutical companies. The Company operates from a 20 acre site in Dhaka and currently employs over 2,400 staff.

The Company’s products are sold to retail outlets, medical institutions and other pharmaceutical manufacturers in Bangladesh, in regional markets such as Sri Lanka, Nepal, Bhutan, Vietnam, Cambodia and Myanmar and in other markets overseas, principally in East Africa, Pacific Island and Central American countries and South East Asia, including Singapore and Hong Kong.

Juliet Edwards Assistant Financial Communications

Holborn Gate, 26 Southampton Buildings London, WC2A 1PB T +44 (0)20 7269 7125 F +44 (0)20 7242 8695

www.fd.com


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES